dexmedetomidine + propofol

Dexmedetomidine + propofol is a combination of two intravenous sedative agents used primarily for procedural sedation, monitored anesthesia care, and intensive care unit (ICU) sedation. Dexmedetomidine is a selective alpha-2 adrenergic receptor agonist that provides sedative, anxiolytic, and mild analgesic effects without significant respiratory depression. Propofol is a short-acting hypnotic agent that acts as a positive allosteric modulator of the GABA-A receptor, producing rapid onset and offset of sedation or anesthesia. The combination leverages the complementary mechanisms of both drugs to achieve effective sedation with improved cardiovascular stability and reduced adverse effects compared to higher doses of either drug alone. Clinical studies have shown this combination can reduce the incidence of airway obstruction, hypoxia, agitation, and spontaneous movement while maintaining patient comfort and hemodynamic stability[1][4]. In critically ill patients requiring mechanical ventilation or deep sedation (such as in ICU settings), this regimen may allow for lower individual drug dosages and potentially fewer dose-related side effects[2][3].

Brand names

DiprivanPropovenPropofol-LipuroPropofolVet MultidosePropoFlo 28PropoFlo28PropoFlo-28CritifolAnefolAnepolAnesiaAnesproAnesvanAquafolB Braun PropofolBlofopDiprofenDiprofolDisoprivanFresofolGobbifolHiremonHospira PropofolInductofolIV-ProLe Wei JingPrecedexIgalmiDexdomitorSileo

Other names

milk of amnesiadexdor